BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6368 related articles for article (PubMed ID: 3257967)

  • 101. Plasminogen activator inhibitor-type I is a major biosynthetic product of retinal microvascular endothelial cells and pericytes in culture.
    Canfield AE; Schor AM; Loskutoff DJ; Schor SL; Grant ME
    Biochem J; 1989 Apr; 259(2):529-35. PubMed ID: 2497739
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation.
    Katagiri K; Okada K; Hattori H; Yano M
    Eur J Biochem; 1988 Sep; 176(1):81-7. PubMed ID: 3262060
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Alterations in plasminogen activator and inhibitor activity during the differentiation of a human neuroblastoma cell line, SMS-KAN.
    Benjamin LA; McGarry RC; Hart DA
    Cancer Lett; 1989 Feb; 44(2):101-8. PubMed ID: 2537681
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro.
    Karlan BY; Amin W; Band V; Zurawski VR; Littlefield BA
    Gynecol Oncol; 1988 Sep; 31(1):103-12. PubMed ID: 3410341
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells.
    Diamond SL; Eskin SG; McIntire LV
    Science; 1989 Mar; 243(4897):1483-5. PubMed ID: 2467379
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines.
    Cajot JF; Kruithof EK; Schleuning WD; Sordat B; Bachmann F
    Int J Cancer; 1986 Nov; 38(5):719-27. PubMed ID: 3490446
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Messenger RNA for plasminogen activator inhibitor.
    Sawdey M; Ny T; Loskutoff DJ
    Thromb Res; 1986 Jan; 41(2):151-60. PubMed ID: 3485834
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Tissue plasminogen activator inhibitor in the epidermis.
    Hashimoto K; Katayama I; Nishioka K
    Br J Dermatol; 1985 Nov; 113(5):523-7. PubMed ID: 3933540
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Plasminogen activator inhibitors from placenta and fibrosarcoma cells are antigenically different as evaluated with monoclonal and polyclonal antibodies.
    Nielsen LS; Lecander I; Andreasen PA; Henschen A; Astedt B; Danø K
    Thromb Res; 1987 May; 46(3):411-23. PubMed ID: 2440126
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Complex formation between plasminogen activator inhibitor 1 and vitronectin in purified systems and in plasma.
    Sigurdardóttir O; Wiman B
    Biochim Biophys Acta; 1990 Jul; 1035(1):56-61. PubMed ID: 1696502
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Enhancement by interleukin-1 (IL-1) of plasminogen activator inhibitor (PA-I) activity in cultured human endothelial cells.
    Grames M; Breviario F; Pintucci G; Millet I; Dejana E; van Damme J; Donati MB; Mussoni L
    Biochem Biophys Res Commun; 1986 Sep; 139(2):720-7. PubMed ID: 3490260
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells.
    Schleuning WD; Medcalf RL; Hession C; Rothenbühler R; Shaw A; Kruithof EK
    Mol Cell Biol; 1987 Dec; 7(12):4564-7. PubMed ID: 3325828
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Cloned cDNA sequence for the human mesothelial protein 'mesosecrin' discloses its identity as a plasminogen activator inhibitor (PAI-1) and a recent evolutionary change in transcript processing.
    Cicila GT; O'Connell TM; Hahn WC; Rheinwald JG
    J Cell Sci; 1989 Sep; 94 ( Pt 1)():1-10. PubMed ID: 2613765
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The pharmacokinetics of plasminogen activator inhibitor-1 in the rabbit.
    Mayer EJ; Fujita T; Gardell SJ; Shebuski RJ; Reilly CF
    Blood; 1990 Oct; 76(8):1514-20. PubMed ID: 2207327
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients.
    Angelici E; Contini C; Romani R; Epifano O; Serra P; Canipari R
    AIDS; 1996 Mar; 10(3):283-90. PubMed ID: 8882668
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterization.
    Booth NA; MacGregor IR; Hunter NR; Bennett B
    Eur J Biochem; 1987 Jun; 165(3):595-600. PubMed ID: 3496217
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A comparison between activated protein C and des-1-41-light chain-activated protein C in reactions with type 1 plasminogen activator inhibitor.
    Gladson CL; Schleef RR; Binder BR; Loskutoff DJ; Griffin JH
    Blood; 1989 Jul; 74(1):173-81. PubMed ID: 2787675
    [TBL] [Abstract][Full Text] [Related]  

  • 118. [Plasminogen activator inhibitor activity of cultured normal human fibroblasts].
    Ueda M; Jimbo T; Ichihashi M; Imokawa G; Hirata M; Fujiwara Y
    Nihon Hifuka Gakkai Zasshi; 1984 Dec; 94(14):1609-14. PubMed ID: 6335899
    [No Abstract]   [Full Text] [Related]  

  • 119. [Plasminogen activator inhibitor-2].
    Niiya K
    Rinsho Byori; 1990 Jul; Suppl 86():100-8. PubMed ID: 2232231
    [No Abstract]   [Full Text] [Related]  

  • 120. A novel assay to measure plasminogen activation capacity in tissue culture on concanavalin A-sepharose.
    Spencer-Green G
    Thromb Res; 1994 Jun; 74(6):665-72. PubMed ID: 8091407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 319.